Form 4 for ALT Altimmune, Inc.
Accepted 2023-02-02 00:00:00 ET · period of report 2023-01-31 · accession 0001104659-23-009972 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-02-02 | 2023-01-31 | ALT | Eisenstadt Richard I | CFO | A - Grant | $10.21 | +1,172 | 12.0K | +11% | +$12.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.0001 | 2023-01-31 | A | A | 1,172 | $10.21 | 12,010 | D | — | — | (F2) In accordance with the ESPP, these shares were purchased based on 85% of the opening price of the issuer's common stock on August 1, 2022. |